Gyre Therapeutics
GYRE----
Forecast & Rating3 analysts currently cover Gyre Therapeutics, of which 3 give a positive rating. The average price target is $18.67, about 214.3% upside from the current price of $5.94. Coverage is limited, so the data is for reference only. Data as of Jun 5, 2026; this does not constitute investment advice.
Jun 5, 2026Price forecast
$18.67214.25%
Forecast & RatingStrong buy
3analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast baselineJul 23, 2026
Forecast met0.0%
Stock price$5.94
Average forecast price$18.7
Highest forecast price$20
Lowest forecast price$18
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.